Cornerstone Capital Management Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$6.38M	Buy	26,736 +133	+0.5%	+$32.2K	0.04%	388
2017 Q3	$5.91M	Sell	26,603 -263	-1%	-$59.2K	0.05%	387
2017 Q2	$6.08M	Buy	26,866 +23,618	+727%	+$5.15M	0.05%	390
2017 Q1	$646K	Buy	+3,248	New	+$626K	0.01%	1007
2016 Q3	–	Sell	-8,025	Closed	-$1.15M	–	1368
2016 Q2	$1.15M	Sell	8,025 -17,475	-69%	-$2.49M	0.01%	867
2016 Q1	$3.49M	Sell	25,500 -3,022	-11%	-$397K	0.03%	565
2015 Q4	$3.96M	Sell	28,522 -10,089	-26%	-$1.4M	0.03%	513
2015 Q3	$5.19M	Sell	38,611 -5,500	-12%	-$792K	0.05%	428
2015 Q2	$6.64M	Buy	44,111 +40,090	+997%	+$5.74M	0.06%	370
2015 Q1	$544K	Sell	4,021 -750	-16%	-$93K	0.01%	999
2014 Q4	$575K	Buy	4,771 +2,698	+130%	+$311K	0.01%	960
2014 Q3	$235K	Buy	+2,073	New	+$246K	﹤0.01%	1081

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HCM

Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cornerstone Capital Management Holdings's BIO Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Bio-Rad Laboratories Class A (BIO) stake by 0.5% in Q4 2017, buying an estimated $32.2K and bringing the position to 26,736 shares worth $6.38M. The position accounts for 0.04% of the portfolio, ranked #388.

Cornerstone Capital Management Holdings first reported a position in BIO in Q3 2014 and has held it in 12 quarters since. The position peaked at $6.64M in Q2 2015. 302 funds tracked by Wall St. Rank hold BIO as of Q4 2017.

Cornerstone Capital Management Holdings held 26,736 shares of Bio-Rad Laboratories Class A worth $6.38M as of Q4 2017.
Cornerstone Capital Management Holdings bought 133 Bio-Rad Laboratories Class A shares in Q4 2017, an estimated $32.2K.
Bio-Rad Laboratories Class A made up 0.04% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #388 holding.
Cornerstone Capital Management Holdings first reported a position in Bio-Rad Laboratories Class A in Q3 2014 and has held it in 12 quarters since.
Cornerstone Capital Management Holdings's Bio-Rad Laboratories Class A position peaked at $6.64M in Q2 2015.
302 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.